{"id":7853,"date":"2025-09-03T17:15:33","date_gmt":"2025-09-03T11:45:33","guid":{"rendered":"https:\/\/chiralpedia.com\/blog\/?p=7853"},"modified":"2025-09-04T10:13:41","modified_gmt":"2025-09-04T04:43:41","slug":"part-3-nomenclature-and-configuration","status":"publish","type":"post","link":"https:\/\/chiralpedia.com\/blog\/part-3-nomenclature-and-configuration\/","title":{"rendered":"Part 3: Nomenclature and Configuration"},"content":{"rendered":"\n<p><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">\u201cDecoding the rules: how chemists name and navigate molecular twists.\u201d<\/mark><\/strong> <\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-81c47aea2e5cee11d71e578c65a2be9b\"><strong>Introduction<\/strong><\/p>\n\n\n\n<p>Correctly describing the stereochemistry of a molecule is as important as understanding it. In this part, we focus on the <strong>Cahn\u2013Ingold\u2013Prelog (CIP) system<\/strong>, which provides the rules for unambiguous assignment of absolute configuration at stereocenters (R\/S) and for double bond geometry <strong>(E\/Z) system<\/strong>. We will outline the CIP priority rules step-by-step and demonstrate how to apply them to pharmaceutical molecules. Additionally, we will discuss older nomenclature systems (like D\/L and cis\/trans) in passing and why CIP is the preferred standard. By using examples from drug molecules, we\u2019ll see how stereochemical nomenclature is used in practice (e.g., distinguishing (R)- from (S)-thalidomide, or E- from Z-tamoxifen). A visual flowchart for R\/S assignment will be suggested as a learning tool to accompany the textual rules.<\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-38a4af80ab3a3196a66a6070b5a0c252\"><strong>CIP Priority Rules \u2013 Assigning R and S<\/strong><\/p>\n\n\n\n<p>The CIP system, devised by chemists<a href=\"https:\/\/en.wikipedia.org\/wiki\/Robert_Sidney_Cahn\" data-type=\"link\" data-id=\"https:\/\/en.wikipedia.org\/wiki\/Robert_Sidney_Cahn\"> R. S. Cahn<\/a>, <a href=\"https:\/\/en.wikipedia.org\/wiki\/Christopher_Kelk_Ingold\" data-type=\"link\" data-id=\"https:\/\/en.wikipedia.org\/wiki\/Christopher_Kelk_Ingold\">C. K. Ingold<\/a>, and <a href=\"https:\/\/en.wikipedia.org\/wiki\/Vladimir_Prelog\" data-type=\"link\" data-id=\"https:\/\/en.wikipedia.org\/wiki\/Vladimir_Prelog\">V. Prelog<\/a> in the mid-20th century, is endorsed by IUPAC for specifying absolute configurations of chirality centers. Each stereocenter is assigned either R (<em>rectus<\/em>, Latin for right) or S (<em>sinister<\/em>, Latin for left) according to the following sequence of rules:<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li><strong>Assign Priority to Substituents:<\/strong> Look at the four atoms directly bonded to the chiral center. Rank them by atomic number: the higher the atomic number, the higher the priority. For example, consider a carbon with substituents H, OCH<sub>3<\/sub>, NH<sub>2<\/sub>, and CH<sub>3<\/sub>: Oxygen (atomic #8) takes highest priority, then nitrogen (#7), then carbon (#6, the methyl), and hydrogen (#1) is lowest. If two substituents begin with the same atom type, move outward along the chain to find the first point of difference (the first place where the groups differ in atomic number). For instance, between an ethyl (\u2013CH<sub>2<\/sub>CH<sub>3<\/sub>) and a methyl (\u2013CH<sub>3<\/sub>) substituent: the first atom in each is carbon (tie), then compare the next set of attached atoms \u2013 ethyl has another carbon attached (next to the first carbon), whereas methyl has only hydrogens. Carbon outranks hydrogen, so ethyl wins over methyl. Double or triple bonds are treated as if the atom is bonded to multiple phantom atoms: e.g., C=O is considered as if carbon is attached to two oxygen atoms for priority purposes. Isotopes: the heavier isotope gets higher priority (e.g., T (tritium) &gt; D (deuterium) &gt; H).<\/li>\n\n\n\n<li><strong>Orient the Molecule:<\/strong> Once priorities 1 (highest) through 4 (lowest) are assigned, mentally orient the molecule (or physically with a model) so that the lowest priority group (4) is pointing <strong>away from you<\/strong> (i.e., its bond to the chiral center is directed into the page). In wedge-dash terms, that usually means the lowest priority should be on a dashed bond if possible. If the lowest priority substituent is not conveniently placed away, one trick is to make a mental (or drawn) swap or rotate the molecule accordingly \u2013 but be cautious: swapping two groups on a stereocenter inverts its configuration, so if you do an odd number of swaps to get the low priority in back, you must invert your result at the end. A reliable method is to use a molecular model or draw a Fischer projection (with lowest priority on a vertical line, which points away in Fischer convention.<\/li>\n\n\n\n<li><strong>Trace a Path from 1\u21922\u21923:<\/strong> With the lowest priority behind, draw or imagine an arrow that goes from priority 1 substituent to priority 2 to priority 3 in order. Do this in the plane of the page (the chiral center is the vertex where substituents attach).<\/li>\n\n\n\n<li><strong>Assign R or S:<\/strong> If the path 1\u20132\u20133 is <strong>clockwise<\/strong>, the center is R (think \u201cRight-turn = Rectus\u201d). If the path is <strong>counter-clockwise<\/strong>, the center is S. An easy mnemonic: imagine a clock dial facing you; if you go from 12\u21923\u21926, that\u2019s clockwise (R). Or use the latin: <em>rectus<\/em> means right, which on a compass is East, and East on most maps is to the right \u2013 a stretch, but it helps some students.<\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"852\" height=\"547\" src=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-02-visual-selection.png\" alt=\"\" class=\"wp-image-8192\" style=\"width:604px;height:auto\" srcset=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-02-visual-selection.png 852w, https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-02-visual-selection-300x193.png 300w, https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-02-visual-selection-768x493.png 768w\" sizes=\"auto, (max-width: 852px) 100vw, 852px\" \/><figcaption class=\"wp-element-caption\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">CIP System &#8211; Assigning Absolute Configuration to a stereogenic center<\/mark> <br><em>Note: For a detailed discussion checkout following blog @&lt;<a href=\"https:\/\/chiralpedia.com\/blog\/naming-enantiomers-the-r-s-system\/\">https:\/\/chiralpedia.com\/blog\/naming-enantiomers-the-r-s-system\/<\/a>&gt;.<\/em><\/figcaption><\/figure>\n\n\n\n<p>Case Study 1: <strong>Thalidomide<\/strong><\/p>\n\n\n\n<p>For example, let\u2019s apply this to a simple pharmaceutical molecule:<a href=\"https:\/\/chiralpedia.com\/blog\/thalidomide\/\" data-type=\"link\" data-id=\"https:\/\/chiralpedia.com\/blog\/thalidomide\/\"> <em>thalidomide<\/em><\/a>. Thalidomide has one chiral center (at the glutaramide ring carbon). Assigning CIP priorities: substituents are (1) the phthalimido group (which begins with a Nitrogen  attached to two carbonyls \u2013 treat as N attached to two \u201cO\u201d phantom atoms, giving that carbon a high priority), (2) the amide carbonyl group (C attached to O, etc.), (3) the adjacent CH<sub>2<\/sub> group, and (4) hydrogen. Without going into exhaustive detail, if we do the exercise, one can determine one enantiomer is (R)-thalidomide and the other (S)-thalidomide.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"621\" height=\"334\" src=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Thalidomide-CIP-2025-chiralpedia-blog-3.png\" alt=\"\" class=\"wp-image-7991\" style=\"width:618px;height:auto\" srcset=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Thalidomide-CIP-2025-chiralpedia-blog-3.png 621w, https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Thalidomide-CIP-2025-chiralpedia-blog-3-300x161.png 300w\" sizes=\"auto, (max-width: 621px) 100vw, 621px\" \/><figcaption class=\"wp-element-caption\"> <em>A step-by-step process (Figure above) illustrate this: it shows identifying substituents, ranking by atomic number (perhaps drawing out the immediate atoms and their neighbors), positioning the lowest priority (H) away, then drawing the 1-2-3 circle to see R or S. Atom priority is assigned based on atomic number as per CIP rule.<\/em>                                                                 <strong><em>Note that enantiomers will have opposite configuration at all the stereogenic centers.<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n<p>A critical point: R and S are labels for <em>absolute configuration<\/em>. They do not tell us which enantiomer rotates light which way \u2013 that must be determined experimentally or by correlation with known standards. For instance, (R)-thalidomide is often cited as the teratogenic one and (S)-thalidomide as the sedative, but in reality thalidomide racemizes in vivo (see Part 6). <\/p>\n\n\n\n<p>Case Study 2:<strong> Ibuprofen<\/strong><\/p>\n\n\n\n<p>As another example, the anti-inflammatory drug ibuprofen is marketed as a racemate, but the active eutomer is S-(+)-ibuprofen. Here S- is the CIP absolute configuration and \u201c+\u201d indicates the direction of optical rotation of that enantiomer in solution. The other enantiomer is R-(\u2013)-ibuprofen, which is weaker as an analgesic but partly converted to S in the body. This convention of prefixing a molecule name with (R)- or (S)- (and if relevant, (+) or (\u2013)) is ubiquitous in medicinal chemistry literature to precisely specify which stereoisomer is being discussed.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"297\" height=\"214\" src=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Ibuprofe-CIP.png\" alt=\"\" class=\"wp-image-7997\" style=\"width:449px;height:auto\"\/><figcaption class=\"wp-element-caption\"><em><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">Ibuprofen &#8211; Anti-inflammatory agent <\/mark><\/em><br><em><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-ast-global-color-1-color\">Priority assigned for substituents as per CIP conventio<\/mark><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">n<\/mark><\/em><\/figcaption><\/figure>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-2423044614230a1b6752bb3e9151df9d\"><strong>E\/Z for Double Bonds<\/strong><\/p>\n\n\n\n<p>In addition to chiral centers, stereochemistry can arise from double bonds (geometric isomerism). The CIP system extends to assign <strong>E<\/strong> (<em>entgegen<\/em>, German \u201copposite\u201d) or <strong>Z<\/strong> (<em>zusammen<\/em>, \u201ctogether\u201d) for C=C bonds, replacing the older \u201ccis\/trans\u201d notation when there are more than two different substituents involved. Here\u2019s how to do it:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>For a given double bond, consider each double-bonded carbon separately. Apply CIP priority rules to the two substituents on that carbon. Do the same for the other carbon. Now you\u2019ve identified a \u201chigher priority\u201d and \u201clower priority\u201d substituent on each end of the C=C.<\/li>\n\n\n\n<li>If the two higher priority substituents are on the <strong>same side<\/strong> of the double bond (i.e., both \u201cup\u201d or both \u201cdown\u201d in a planar depiction), the double bond configuration is <strong>Z<\/strong> (\u201czusammen\u201d). If they are on <strong>opposite sides<\/strong> (one \u201cup\u201d and one \u201cdown\u201d), it\u2019s <strong>E<\/strong> (\u201centgegen\u201d).<\/li>\n<\/ul>\n\n\n\n<p>Read more @ the following blog article &lt;<a href=\"https:\/\/chiralpedia.com\/blog\/cis-trans-and-e-z-notation-choose-your-side\/\">https:\/\/chiralpedia.com\/blog\/cis-trans-and-e-z-notation-choose-your-side\/<\/a>&gt;<\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color wp-elements-74eae094cee6709a632e2114f3c234fb\">Case Study: Tamoxifen<\/p>\n\n\n\n<p>The drug <em>tamoxifen<\/em>, a selective estrogen receptor modulator. Tamoxifen has a C=C in its structure (in the triphenylethylene core). If we assign priorities on each end (the substituted phenyl vs. H on one end, and two different substituted aryl groups on the other), one finds that tamoxifen\u2019s active form is the <strong>E<\/strong> isomer (often loosely called trans-tamoxifen). The Z isomer (cis) is inactive as an ER modulator. In simpler cases where each carbon has one H, cis\/trans and E\/Z coincide (cis = Z, trans = E). But for clarity, especially in polysubstituted alkenes, E\/Z is used.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"392\" height=\"496\" src=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Tamoxifen-1.png\" alt=\"\" class=\"wp-image-8067\" style=\"width:412px;height:auto\" srcset=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Tamoxifen-1.png 392w, https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/Tamoxifen-1-237x300.png 237w\" sizes=\"auto, (max-width: 392px) 100vw, 392px\" \/><figcaption class=\"wp-element-caption\">(1) &#8211; indicates higher priority and (2) &#8211; indicates lower priority<\/figcaption><\/figure>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color wp-elements-0723b093edc9056dcf5637b45fc73c84\">Case Study:  Retinoic acid<\/p>\n\n\n\n<p> Another pharmaceutical example: <em>retinoic acid<\/em> exists as all-trans (tretinoin) and 13-cis (isotretinoin) forms. Here, because there are multiple double bonds, a full E\/Z designation can be given to each, but they are commonly known by cis\/trans in reference to the terminal double bond. Tretinoin (all-E-retinoic acid) and isotretinoin (13-cis-retinoic acid) have different therapeutic uses (tretinoin for leukemia and dermatology; isotretinoin for acne) and different safety profiles, illustrating the importance of double bond stereochemistry.<\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-d18f32d3b3a73dea2c6debc297e7b371\"><strong><em>Cis-trans<\/em>\u00a0Isomerism due to Double bonded carbon-heteroatom\u00a0systems<\/strong><\/p>\n\n\n\n<p>For a discussion <em>on Cis-trans isomerism due to double bonded carbon\u2013heteroatom systems (<strong>oximes<\/strong> and <strong>azo <\/strong>compounds) refer to our  earlier blog<\/em> on  &#8220;Cis-trans and E-Z notation: choose your side&#8221;<em>  <\/em>@ &lt;<a href=\"https:\/\/chiralpedia.com\/blog\/cis-trans-and-e-z-notation-choose-your-side\/\">https:\/\/chiralpedia.com\/blog\/cis-trans-and-e-z-notation-choose-your-side\/<\/a>>.<\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-4361f00d2e91eda6d57875bd83fc82e5\"><strong>Example \u2013 Nomenclature in Drug Names<\/strong><\/p>\n\n\n\n<p>If you read the full chemical name of a drug in a scientific insert or regulation, it often encodes stereochemistry. For instance, the anticoagulant <strong>clopidogrel<\/strong> is marketed as the single stereoisomer (the <em>SR<\/em> diastereomer, with absolute configuration (S) at one center and (R) at another \u2013 sometimes denoted as (\u2013)-clopidogrel in older literature). Its IUPAC name includes both stereo-descriptors. As another example, <strong>esomeprazole<\/strong> \u2013 as mentioned earlier \u2013 is the S-enantiomer of omeprazole. In publications you might see it named \u201c(S)-omeprazole\u201d. The FDA label even refers to esomeprazole magnesium trihydrate as \u201cthe S-isomer of omeprazole\u201d (hence the brand name Nexium\u2019s implication as the next-generation single-isomer). The ability to decode R\/S and E\/Z in drug names allows a chemist or pharmacist to understand which stereochemical form is present. Regulatory authorities often require that the absolute configuration be determined and indicated for chiral drugs \u2013 for example, the FDA\u2019s 1992 policy states absolute stereochemistry should be established early in development.<\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-b6bc6adc0406b36494ab79cd19e405e7\"><strong>Fischer vs. CIP (D\/L system)<\/strong><\/p>\n\n\n\n<p>Before<strong> CIP<\/strong>, sugars and amino acids were assigned D or L configurations relative to a reference (glyceraldehyde). This <strong>D\/L system<\/strong> is still used in biochemistry (e.g., L-amino acids, D-glucose) but it is a relative notation, not an absolute one except by historical convention. For instance, natural L-amino acids are usually (S) by CIP rules (with the notable exception of cysteine which is (R) due to sulfur\u2019s priority). The D\/L system does not generalize well beyond certain families of compounds and is not used for most pharmaceuticals (except those directly derived from sugars or amino acids where tradition persists). CIP R\/S is universal and unambiguous. Similarly, the older <strong>cis\/trans<\/strong> for rings or alkenes becomes inadequate when more substituents are involved or in complex rings \u2013 hence <strong>E\/Z<\/strong> is preferred for double bonds in IUPAC names. In rings, terms like cis\/trans are still used (e.g., cis-atracurium), but often one can specify configurations at each stereocenter for clarity.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"684\" height=\"492\" src=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-03-visual-selection.png\" alt=\"\" class=\"wp-image-8186\" style=\"width:500px;height:auto\" srcset=\"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-03-visual-selection.png 684w, https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2025\/07\/SC-P3-03-visual-selection-300x216.png 300w\" sizes=\"auto, (max-width: 684px) 100vw, 684px\" \/><figcaption class=\"wp-element-caption\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">Overview of Nomenclature Systems<\/mark><\/figcaption><\/figure>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-ddf70872f18c4da30acf16bddbc25570\"><strong>Summary (Part 3)<\/strong><\/p>\n\n\n\n<p>&#8211; The <strong>CIP system<\/strong> provides a rigorous method to assign absolute configuration (R or S) to chiral centers and geometric configuration (E or Z) to double bonds.<br>&#8211; <strong>Priority rules:<\/strong> Based on atomic number (and connectivity for ties); these rules are applied to determine ordering of substituents.<br>&#8211; <strong>Assigning R\/S:<\/strong> After ranking, orient the molecule with the lowest priority substituent away and see if the 1-2-3 sequence goes clockwise (R) or counter-clockwise (S). This gives the absolute stereochemistry of that center.<br>&#8211; <strong>Assigning E\/Z:<\/strong> Determine high-priority substituent on each double bond carbon, then check positions \u2013 same side = Z, opposite sides = E. Useful for specifying alkene isomers unambiguously, especially when cis\/trans nomenclature fails.<br>&#8211; Pharmaceutical examples illustrate use of this nomenclature: (S)-omeprazole vs racemic omeprazole, (R,R)-formoterol vs (S,S)-formoterol (enantiomeric pairs of a bronchodilator, where only one is marketed), etc.<br>&#8211; <strong>Why it matters:<\/strong> Precise stereochemical nomenclature avoids ambiguity \u2013 critical in drug patents, regulatory filings, and medicinal chemistry publications. It tells chemists exactly which stereoisomer is present or being made, which is crucial given that different stereoisomers can have very different properties. Regulatory agencies expect that sponsors characterize the stereochemistry of chiral drugs and use the proper nomenclature in documentation.<br>&#8211; <strong>Older nomenclatures:<\/strong> D\/L and cis\/trans are either limited or context-dependent and have largely been superseded in formal use by CIP descriptors for clarity, though you will still encounter them (especially D\/L in biochemistry).<\/p>\n\n\n\n<p class=\"has-ast-global-color-0-color has-text-color has-link-color has-medium-font-size wp-elements-2c38cbc70272fb18272d487f64c46472\"><strong>Suggested Reading<\/strong><\/p>\n\n\n\n<p> IUPAC Rules (1976, 1982, etc.) for Stereochemical Nomenclature \u2013 the foundational papers by Cahn, Ingold, Prelog (e.g., <em>Angew. Chem. Int. Ed.<\/em>, 1966, 5, 385) detailing the CIP system. (Classic primary literature on CIP rules.)<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-chiralpedia wp-block-embed-chiralpedia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"OSwJRLOw5f\"><a href=\"https:\/\/chiralpedia.com\/blog\/mapping-stereochemical-nomenclature-a-chiralpedia-guide\/\">Mapping Stereochemical Nomenclature: A Chiralpedia Guide<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Mapping Stereochemical Nomenclature: A Chiralpedia Guide&#8221; &#8212; Chiralpedia\" src=\"https:\/\/chiralpedia.com\/blog\/mapping-stereochemical-nomenclature-a-chiralpedia-guide\/embed\/#?secret=gexefBOLHY#?secret=OSwJRLOw5f\" data-secret=\"OSwJRLOw5f\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>IUPAC Blue Book (Nomenclature of Organic Chemistry), latest edition \u2013 section on stereo-descriptors (R\/S and E\/Z). (The official nomenclature manual with examples.)<\/p>\n\n\n\n<p> \u201cSequence Rules for Specifying Configuration (R\/S)\u201d \u2013 Chemistry LibreTexts section. (A tutorial-like explanation with interactive examples.) &#8211; <a href=\"https:\/\/chem.libretexts.org\/Courses\/Purdue\/Chem_26505%3A_Organic_Chemistry_I_(Lipton)\/Chapter_3._Stereochemistry\/3.6_Cahn-Ingold_Prelog_Rules#:~:text=If%20there%20are%20two%20substituents,chain%20has%20the%20higher%20priority\">https:\/\/chem.libretexts.org\/Courses\/Purdue\/Chem_26505%3A_Organic_Chemistry_I_(Lipton)\/Chapter_3._Stereochemistry\/3.6_Cahn-Ingold_Prelog_Rules#:~:text=If%20there%20are%20two%20substituents,chain%20has%20the%20higher%20priority<\/a><br>FDA Guidance 1992 \u2013 <em>Appendix<\/em> or relevant part where they emphasize knowing absolute stereochemistry<a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/development-new-stereoisomeric-drugs#:~:text=Now%20that%20technological%20advances%20,of%20many%20single%20enantiomers\">[46]<\/a>. (Regulatory angle on importance of correct stereochemical assignment.)<\/p>\n\n\n\n<p>Hinchliffe, A. (2018). <em>Chemical Nomenclature<\/em> (Chapman &amp; Hall): Chapter on stereochemical nomenclature. (A concise guide with many examples, covering CIP, and also discussing pitfalls and special cases like atropisomers, etc.)<\/p>\n\n\n\n<p>.<a href=\"https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/619871-Chiral-Separation-and-Enantiomeric-Analysis-Critical-Importance-in-Pharmaceutical-Development\">https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/619871-Chiral-Separation-and-Enantiomeric-Analysis-Critical-Importance-in-Pharmaceutical-Development<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/en.wikipedia.org\/wiki\/Chiral_drugs\">https:\/\/en.wikipedia.org\/wiki\/Chiral_drugs<\/a><\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-chiralpedia wp-block-embed-chiralpedia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"KYf0NocRdF\"><a href=\"https:\/\/chiralpedia.com\/blog\/naming-enantiomers-the-r-s-system\/\">Naming enantiomers: the left-(or right-) handed?<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Naming enantiomers: the left-(or right-) handed?&#8221; &#8212; Chiralpedia\" src=\"https:\/\/chiralpedia.com\/blog\/naming-enantiomers-the-r-s-system\/embed\/#?secret=3VrNvSSNXr#?secret=KYf0NocRdF\" data-secret=\"KYf0NocRdF\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-chiralpedia wp-block-embed-chiralpedia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"YpTl1WAItv\"><a href=\"https:\/\/chiralpedia.com\/blog\/fischer-projection-hassle-free-way-to-depict-a-stereoformula-in-2d\/\">Fischer Projection: hassle free way to depict a stereoformula in 2D projection\u00a0<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Fischer Projection: hassle free way to depict a stereoformula in 2D projection\u00a0&#8221; &#8212; Chiralpedia\" src=\"https:\/\/chiralpedia.com\/blog\/fischer-projection-hassle-free-way-to-depict-a-stereoformula-in-2d\/embed\/#?secret=WYXY7OtF9h#?secret=YpTl1WAItv\" data-secret=\"YpTl1WAItv\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<p><a href=\"https:\/\/chem.libretexts.org\/Ancillary_Materials\/Reference\/Organic_Chemistry_Glossary\/Fischer_Projection#:~:text=Step%201%3A%20Hold%20the%20molecule,so%20that\">https:\/\/chem.libretexts.org\/Ancillary_Materials\/Reference\/Organic_Chemistry_Glossary\/Fischer_Projection#:~:text=Step%201%3A%20Hold%20the%20molecule,so%20that<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/chem.libretexts.org\/Bookshelves\/Organic_Chemistry\/Organic_Chemistry_(Morsch_et_al.)\/07%3A_Alkenes-Structure_and_Reactivity\/7.06%3A_Sequence_Rules-_The_EZ_Designation#:~:text=7.6%3A%20Sequence%20Rules%20,a%20high%20or%20low%20priority\">https:\/\/chem.libretexts.org\/Bookshelves\/Organic_Chemistry\/Organic_Chemistry_(Morsch_et_al.)\/07%3A_Alkenes-Structure_and_Reactivity\/7.06%3A_Sequence_Rules-_The_EZ_Designation#:~:text=7.6%3A%20Sequence%20Rules%20,a%20high%20or%20low%20priority<\/a><\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-chiralpedia wp-block-embed-chiralpedia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"S8jFfLkeHI\"><a href=\"https:\/\/chiralpedia.com\/blog\/d-l-system-naming-the-left-or-right-hand-side\/\">D-\/L- system naming: the (left-) or (right-) hand side?<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;D-\/L- system naming: the (left-) or (right-) hand side?&#8221; &#8212; Chiralpedia\" src=\"https:\/\/chiralpedia.com\/blog\/d-l-system-naming-the-left-or-right-hand-side\/embed\/#?secret=PkNplnyUfI#?secret=S8jFfLkeHI\" data-secret=\"S8jFfLkeHI\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<p><a href=\"https:\/\/chem.libretexts.org\/Bookshelves\/Organic_Chemistry\/Organic_Chemistry_(Morsch_et_al.)\/07%3A_Alkenes-Structure_and_Reactivity\/7.06%3A_Sequence_Rules-_The_EZ_Designation#:~:text=7.6%3A%20Sequence%20Rules%20,a%20high%20or%20low%20priority\">https:\/\/chem.libretexts.org\/Bookshelves\/Organic_Chemistry\/Organic_Chemistry_(Morsch_et_al.)\/07%3A_Alkenes-Structure_and_Reactivity\/7.06%3A_Sequence_Rules-_The_EZ_Designation#:~:text=7.6%3A%20Sequence%20Rules%20,a%20high%20or%20low%20priority<\/a><\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-chiralpedia wp-block-embed-chiralpedia\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"qBpTkKhBHT\"><a href=\"https:\/\/chiralpedia.com\/blog\/cis-trans-and-e-z-notation-choose-your-side\/\">Cis-trans and E-Z notation: choose your side<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Cis-trans and E-Z notation: choose your side&#8221; &#8212; Chiralpedia\" src=\"https:\/\/chiralpedia.com\/blog\/cis-trans-and-e-z-notation-choose-your-side\/embed\/#?secret=yMY954gUBH#?secret=qBpTkKhBHT\" data-secret=\"qBpTkKhBHT\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>\u201cDecoding the rules: how chemists name and navigate molecular twists.\u201d Introduction Correctly describing the stereochemistry of a molecule is as important as understanding it. In this part, we focus on the Cahn\u2013Ingold\u2013Prelog (CIP) system, which provides the rules for unambiguous assignment of absolute configuration at stereocenters (R\/S) and for double bond geometry (E\/Z) system. We will outline the CIP priority rules step-by-step and demonstrate how to apply them to pharmaceutical molecules. Additionally, we will discuss &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/chiralpedia.com\/blog\/part-3-nomenclature-and-configuration\/\"> <span class=\"screen-reader-text\">Part 3: Nomenclature and Configuration<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":8559,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"","site-content-layout":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[123],"tags":[22,79,25],"ppma_author":[93,95],"class_list":["post-7853","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stereochemistry","tag-chirality","tag-naming_system","tag-stereochemistry"],"authors":[{"term_id":93,"user_id":1,"is_guest":0,"slug":"chiralusrblg","display_name":"Valliappan Kannappan","avatar_url":{"url":"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2024\/09\/vk.jpg","url2x":"https:\/\/chiralpedia.com\/blog\/wp-content\/uploads\/2024\/09\/vk.jpg"},"first_name":"","last_name":"","user_url":"https:\/\/chiralpedia.com\/blog\/","job_title":"Founder, chiralpedia.com","description":""},{"term_id":95,"user_id":2,"is_guest":0,"slug":"chandramouli-r","display_name":"Chandramouli R","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/dafe0b6a18e9248eb688088e3e993360328363d8d087bbd01648f0bddae05eb5?s=96&d=mm&r=g","first_name":"","last_name":"","user_url":"","job_title":"","description":""}],"_links":{"self":[{"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/posts\/7853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/comments?post=7853"}],"version-history":[{"count":36,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/posts\/7853\/revisions"}],"predecessor-version":[{"id":8571,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/posts\/7853\/revisions\/8571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/media\/8559"}],"wp:attachment":[{"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/media?parent=7853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/categories?post=7853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/tags?post=7853"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/chiralpedia.com\/blog\/wp-json\/wp\/v2\/ppma_author?post=7853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}